Quick Answer
Medicus Pharma Ltd. reported Operating Income of -$34.36 million for fiscal year 2025.
Medicus Pharma Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$34.36M | -207.3% |
| 2024 | -$11.18M | -136.4% |
| 2023 | -$4.73M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.00 | +100.0% | +100.0% |
| June 30, 2025 | -$6.02M | -69.3% | -17.4% |
| March 31, 2025 | -$5.13M | -200.2% | -119.6% |
| September 30, 2024 | -$2.33M | — | +34.3% |
| June 30, 2024 | -$3.55M | — | -108.1% |
| March 31, 2024 | -$1.71M | — | — |
- Medicus Pharma Ltd. showed a decrease of -207.3% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Medicus Pharma Ltd.’s operating income has declined by 626.4% (from -$4.73 million to -$34.36 million).
- The most recent figure is from Medicus Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: